Literature DB >> 12791267

Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase.

Florence Margottin-Goguet1, Jerry Y Hsu, Alexander Loktev, Harn Mei Hsieh, Julie D R Reimann, Peter K Jackson.   

Abstract

Progression through mitosis occurs because cyclin B/Cdc2 activation induces the anaphase promoting complex (APC) to cause cyclin B destruction and mitotic exit. To ensure that cyclin B/Cdc2 does not prematurely activate the APC in early mitosis, there must be a mechanism delaying APC activation. Emi1 is a protein capable of inhibiting the APC in S and G2. We show here that Emi1 is phosphorylated by Cdc2, and on a DSGxxS consensus site, is subsequently recognized by the SCF(betaTrCP/Slimb) ubiquitin ligase and destroyed, thus providing a delay for APC activation. Failure of betaTrCP-dependent Emi1 destruction stabilizes APC substrates and results in mitotic catastrophe including centrosome overduplication, potentially explaining mitotic deficiencies in Drosophila Slimb/betaTrCP mutants. We hypothesize that Emi1 destruction relieves a late prophase checkpoint for APC activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791267     DOI: 10.1016/s1534-5807(03)00153-9

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  155 in total

1.  Emi1-mediated M-phase arrest in Xenopus eggs is distinct from cytostatic factor arrest.

Authors:  Keita Ohsumi; Ayako Koyanagi; Tomomi M Yamamoto; Tetsuya Gotoh; Takeo Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

2.  Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.

Authors:  David V Hansen; Alexander V Loktev; Kenneth H Ban; Peter K Jackson
Journal:  Mol Biol Cell       Date:  2004-10-06       Impact factor: 4.138

Review 3.  Insights into phosphorylation-dependent mechanisms regulating USP1 protein stability during the cell cycle.

Authors:  Xiomaris M Cotto-Rios; Mathew J K Jones; Tony T Huang
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

Review 4.  The role of the ubiquitin-proteasome system in Agrobacterium tumefaciens-mediated genetic transformation of plants.

Authors:  Shimpei Magori; Vitaly Citovsky
Journal:  Plant Physiol       Date:  2012-07-10       Impact factor: 8.340

Review 5.  Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins.

Authors:  Nana Zheng; Zhiwei Wang; Wenyi Wei
Journal:  Int J Biochem Cell Biol       Date:  2016-02-06       Impact factor: 5.085

6.  Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.

Authors:  Ying Li; K G Kuresh Kumar; Weigang Tang; Vladimir S Spiegelman; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 7.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

Review 8.  Posing the APC/C E3 Ubiquitin Ligase to Orchestrate Cell Division.

Authors:  Edmond R Watson; Nicholas G Brown; Jan-Michael Peters; Holger Stark; Brenda A Schulman
Journal:  Trends Cell Biol       Date:  2018-10-25       Impact factor: 20.808

9.  A role for the anaphase-promoting complex inhibitor Emi2/XErp1, a homolog of early mitotic inhibitor 1, in cytostatic factor arrest of Xenopus eggs.

Authors:  Jeffrey J Tung; David V Hansen; Kenneth H Ban; Alexander V Loktev; Matthew K Summers; John R Adler; Peter K Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

Review 10.  The multiple layers of ubiquitin-dependent cell cycle control.

Authors:  Katherine Wickliffe; Adam Williamson; Lingyan Jin; Michael Rape
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.